GlassScriptPhysician profile
Sandeep Kola
NPI 1639584584
$2,622.27
in general payments reported to CMS, 2019-2025
29 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $167 · 2021: $378 · 2022: $520 · 2023: $262 · 2024: $415 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $878.17 | 2019-2025 | Xtampza |
| Abbvie INC. | $410.63 | 2021-2022 | |
| Nevro Corp. | $300.69 | 2019-2022 | |
| Abbott Laboratories | $169.31 | 2024-2025 | Proclaim |
| Idorsia Pharmaceuticals US INC | $125.50 | 2024 | Quviviq |
| Biodelivery Sciences International, INC. | $124.99 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $82.30 | 2025 | |
| Almatica Pharma LLC | $80.03 | 2022-2023 | Gralise |
| Avanos Medical | $42.38 | 2024 | Standard Rf Disposables, Coolief* Cooled Radiofrequency |
| Forte Bio-Pharma LLC | $33.38 | 2025 | Prolate, Tanlor, Nalocet |
| Kowa Pharmaceuticals America, INC. | $32.39 | 2022 | |
| Spr Therapeutics, INC | $29.35 | 2025 | Sprint Pns System |
| Allergan, INC. | $28.06 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $26.70 | 2021 | |
| Si-Bone, INC. | $21.78 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $21.42 | 2022 | |
| Globus Medical, INC. | $21.02 | 2025 | Senza |
| Pacira Therapeutics, INC. | $20.79 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.55 | 2023 | Iovera, Zilretta, Exparel |
| Sonex Health, INC. | $19.15 | 2021 | |
| Pfizer INC. | $18.46 | 2024 | |
| Bioventus LLC | $16.57 | 2021 | |
| Ermi LLC | $16.07 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.08 | 2021 | |
| Azurity Pharmaceuticals, INC. | $14.84 | 2024 | Horizant |
| Depuy Synthes Sales INC. | $14.72 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.76 | 2019 | |
| Medtronic, INC. | $13.47 | 2021 | |
| Fidia Pharma USA INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Kola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.